Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Presenter: Harry Rowland

February 13, 2025

Presentation THT 2025

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Presenter: Alex Cadotte

February 13, 2025

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Presenter: Kartik Sundareswaran

February 13, 2025

Presentation THT 2024

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Presenter: Akhil Narang

March 05, 2024

Presentation THT 2024

Heart Failure Diagnosis Using Wearable Devices

Presenter: Rohan Khera

March 05, 2024

Presentation THT 2024

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Presenter: Christopher Haggerty

March 05, 2024

Presentation THT 2024

Regulatory Aspects of Implementing AI into Heart Failure Diagnostics and Therapeutics

Presenter: Haider Warraich

March 05, 2024

Presentation THT 2024

Growing Role of AI in HF Diagnostics: Are There Any Pitfalls?

Presenter: Partho P. Sengupta

March 05, 2024

Presentation THT 2024

AI in Diagnostics and Therapeutics: Horizons Ahead

Presenter: Harlan Krumholz

March 05, 2024

Presentation THT 2024

Future Care in HF: Sensors, Artificial Intelligence, and Medicine

Presenter: Jagmeet P. Singh

March 04, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

Presentation THT 2023

Artificial Intelligence Will Revolutionize Risk Stratification and Guide Therapy for Cardiogenic Shock

Presenter: Song Li

March 20, 2023

$Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction$

Presentation THT 2023

Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction

Presenter: Hak Seung Lee

March 20, 2023

Advertisement

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

This Strategy Has Saved the Startup Medical Device Sector

Down-Stream Challenges: Reimbursement and Guidelines

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Heart Failure Diagnosis Using Wearable Devices

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Regulatory Aspects of Implementing AI into Heart Failure Diagnostics and Therapeutics

Growing Role of AI in HF Diagnostics: Are There Any Pitfalls?

AI in Diagnostics and Therapeutics: Horizons Ahead

Future Care in HF: Sensors, Artificial Intelligence, and Medicine

The Promise of AI for Improving Health Equity in Heart Failure

Artificial Intelligence Will Revolutionize Risk Stratification and Guide Therapy for Cardiogenic Shock

Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content